Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02848274 · ClinicalTrials.gov registry record
ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
A clinical trial of Non-Hodgkin's Lymphoma and Mycosis Fungoides, sponsored by Stanford University.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 13
- Study locations
NCT02848274: Recruiting study of Non-Hodgkin's Lymphoma and Mycosis Fungoides, sponsored by Stanford University.
NCT02848274 is a study of Non-Hodgkin's Lymphoma and Mycosis Fungoides that is actively recruiting participants, run by Stanford University. The registered enrollment target is 2,000 participants, above the 190-participant average among 63 other Non-Hodgkin's Lymphoma trials with a reported enrollment target (953% higher). The trial reports 13 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02848274, a study of Non-Hodgkin's Lymphoma and Mycosis Fungoides, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 13
- Study locations
Study Summary
The purpose of the study is to develop a prognostic index model for the rare disease of mycosis fungoides and sezary syndrome. This will be done by collecting standardized clinical data at various institutions. The investigators hope this will enable the identification of low- and high-risk groups for survival in order to improve patient care and outcome.
Conditions Studied
Study Locations (13)
Other
- Hospital Italiano de Buenos Aires - Buenos Aires
- Peter MacCallum Cancer Center, - Melbourne
- University of Sao Paulo Medical School - São Paulo
- Peking University First Hospital - Beijing
- The University of Tokyo - Tokyo
- University Hospitals Birmingham - Birmingham
California
- City of Hope - Duarte
- Stanford University, School of Medicine - Palo Alto
Iowa
- University of Iowa - Iowa City
New Jersey
- Hackensack University Medical Center - Hackensack
Pennsylvania
- University of Pittsburg - Pittsburgh
Texas
- University of Texas Southwestern - Dallas
Utah
- University of Utah Hospital - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2016-10 |
| Est. Completion | 2027-03 |
What NCT02848274 shows while recruiting
NCT02848274 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, above the 190-participant average among 63 other Non-Hodgkin's Lymphoma trials with a reported enrollment target (953% higher).
The record links to 2 conditions, with Non-Hodgkin's Lymphoma appearing as the primary indexed condition, and to 0 interventions.
NCT02848274 lists 13 locations in 7 states (Other, California, Iowa).
Frequently Asked Questions
What is clinical trial NCT02848274 about?
NCT02848274 is a clinical study titled "ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome". The purpose of the study is to develop a prognostic index model for the rare disease of mycosis fungoides and sezary syndrome. This will be done by collecting standardized clinical data at various institutions. The investigators hope this will enable the identification of low- and high-risk groups f...
What is the current status of trial NCT02848274?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2016-10. Estimated completion is 2027-03.
What conditions does trial NCT02848274 study?
This clinical trial studies the following conditions: Non-Hodgkin's Lymphoma, Mycosis Fungoides.
Who is sponsoring clinical trial NCT02848274?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02848274 being conducted?
This trial has 13 study locations across California, Iowa, New Jersey, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Non-Hodgkin's Lymphoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02848274's enrollment target sits among peer trials
2,000 2nd of 63 higher than 61 of 63 other Non-Hodgkin's Lymphoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Non-Hodgkin's Lymphoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets
RECRUITING · Phase 1
-
Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE
RECRUITING · Phase 1
-
Cord Blood Transplant in Adults With Blood Cancers
RECRUITING · Phase 2
-
The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
RECRUITING
-
Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies
RECRUITING
-
A Dose Escalation Study of Glofitamab (RO7082859) as a Single Agent and in Combination With Obinutuzumab, Administered After a Fixed, Single Pre-treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-cell Non-hodgkin's Lymphoma
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia